Page 63 - ITPS-7-4

INNOSC Theranostics and
Pharmacological Sciences Drug repositioning for NTDs treatment

of 1,2,3-triazolyl sterols for the development of new drugs development: Kinases as a potential target. Br J Clin
against parasitic Neglected Tropical Diseases. Eur J Med Pharmacol. 2022;88(1):64-74.
Chem. 2023;254:115378.
doi: 10.1111/bcp.14964
doi: 10.1016/j.ejmech.2023.115378
14. Latif T, Chauhan N, Khan R, Moran A, Usmani SZ.
3. Previti S, Di Chio C, Ettari R, et al. Dual inhibition of parasitic Thalidomide and its analogues in the treatment of Multiple
targets: A valuable strategy to treat malaria and neglected Myeloma. Exp Hematol Oncol. 2012;1(1):27.
tropical diseases. Curr Med Chem. 2022;29(17):2952-2978.
doi: 10.1186/2162-3619-1-27
doi: 10.2174/0929867328666210810125309
15. Teo S, Resztak KE, Scheffler MA, et al. Thalidomide in the
4. Magalhães AR, Codeço CT, Svenning JC, et al. Neglected treatment of leprosy. Microbes Infect. 2002;4(11):1193-202.
tropical diseases risk correlates with poverty and early doi: 10.1016/s1286-4579(02)01645-3
ecosystem destruction. Infect Dis Poverty. 2023;12(1):32.
16. Abdelsayed M, Kort EJ, Jovinge S, et al. Repurposing drugs to
doi: 10.1186/s40249-023-01084-1
treat cardiovascular disease in the era of precision medicine.
5. Chami GF, Bundy DAP. More medicines alone cannot Nat Rev Cardiol. 2022;19(11):751-764.
ensure the treatment of neglected tropical diseases. Lancet doi: 10.1038/s41569-022-00717-6
Infect Dis. 2019;19(9):e330-e336.
17. Xia Y, Sun M, Huang H, Jin WL. Drug repurposing for
doi: 10.1016/S1473-3099(19)30160-4
cancer therapy. Signal Transduct Target Ther. 2024;9(1):92.
6. Weng HB, Chen HX, Wang MW. Innovation in neglected doi: 10.1038/s41392-024-01808-1
tropical disease drug discovery and development. Infect Dis
Poverty. 2018;7(1):67. 18. Hijazi MA, Gessner A, El-Najjar N. Repurposing of
chronically used drugs in cancer therapy: A chance to grasp.
doi: 10.1186/s40249-018-0444-1
Cancers (Basel). 2023;15(12):3199.
7. Jourdan JP, Bureau R, Rochais C, Dallemagne P. Drug doi: 10.3390/cancers15123199
repositioning: A brief overview. J Pharm Pharmacol.
2020;72(9):1145-1151. 19. Porta EOJ, Bofill Verdaguer I, Perez C, et al. Repositioning
Salirasib as a new antimalarial agent. Medchemcomm.
doi: 10.1111/jphp.13273
2019;10(9):1599-1605.
8. Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: doi: 10.1039/c9md00298g
Progress, challenges and recommendations. Nat Rev Drug
Discov. 2019;18(1):41-58. 20. Pessanha de Carvalho L, Kreidenweiss A, Held J. Drug
repurposing: A review of old and new antibiotics for the
doi: 10.1038/nrd.2018.168
treatment of malaria: Identifying antibiotics with a fast onset
9. Low ZY, Farouk IA, Lal SK. Drug repositioning: New of antiplasmodial action. Molecules. 2021;26(8):2304.
approaches and future prospects for life-debilitating doi: 10.3390/molecules26082304
diseases and the COVID-19 pandemic outbreak. Viruses.
2020;12(9):1058. 21. Machado PR, Ampuero J, Guimarães LH, et al. Miltefosine
in the treatment of cutaneous leishmaniasis caused by
doi: 10.3390/v12091058
Leishmania braziliensis in Brazil: A randomized and
10. Kulkarni VS, Alagarsamy V, Solomon VR, Jose PA, controlled trial. PLoS Negl Trop Dis. 2010;4(12):e912.
Murugesan S. Drug repurposing: An effective tool in modern doi: 10.1371/journal.pntd.0000912
drug discovery. Russ J Bioorg Chem. 2023;49(2):157-166.
22. Klug DM, Gelb MH, Pollastri MP. Repurposing strategies
doi: 10.1134/S1068162023020139
for tropical disease drug discovery. Bioorg Med Chem Lett.
11. Hua Y, Dai X, Xu Y, et al. Drug repositioning: Progress and 2016;26(11):2569-2576.
challenges in drug discovery for various diseases. Eur J Med doi: 10.1016/j.bmcl.2016.03.103
Chem. 2022;234:114239.
23. Porta EOJ, Kalesh K, Steel PG. Navigating drug repurposing
doi: 10.1016/j.ejmech.2022.114239
for Chagas disease: Advances, challenges, and opportunities.
12. Talevi A, Bellera CL. Challenges and opportunities with drug Front Pharmacol. 2023;14:1233253.
repurposing: Finding strategies to find alternative uses of doi: 10.3389/fphar.2023.1233253
therapeutics. Expert Opin Drug Discov. 2020;15(4):397-401.
24. Charlton RL, Rossi-Bergmann B, Denny PW, et al.
doi: 10.1080/17460441.2020.1704729
Repurposing as a strategy for the discovery of new
13. Islam S, Wang S, Bowden N, Martin J, Head R. Repurposing anti-leishmanials: The-state-of-the-art. Parasitology.
existing therapeutics, its importance in oncology drug 2018;145(2):219-236.

Volume 7 Issue 4 (2024) 7 doi: 10.36922/itps.3721